Clinical Trials Logo
  1. Home
  2. End Stage Renal Disease
  3. NCT06468826

A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)

End-Stage Renal Disease (ESRD) Clinical Trial

Official title:
A Phase 1, Open-label, Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Avacopan in Subjects With Normal Renal Function and Subjects With End-Stage Renal Disease (ESRD) Requiring Hemodialysis

Clinical Trial Summary

The primary objective of the study is to evaluate the pharmacokinetics (PK) of avacopan and metabolite (M1) after a single dose of avacopan in participants with normal renal function and participants with ESRD requiring hemodialysis (HD).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06468826
Study type Interventional
Source Amgen
Contact Amgen Call Center
Phone 866-572-6436
Email medinfo@amgen.com
Status Not yet recruiting
Phase Phase 1
Start date July 9, 2024
Completion date January 10, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT02553889 - A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis Phase 2
Completed NCT01222234 - Impact of Vitamin D Therapies on Chronic Kidney Disease N/A
Recruiting NCT00243958 - Aluminum and Auditory Function in ESRD N/A
Active, not recruiting NCT03989141 - Creating a Buttonhole Tunnel Track by Repeated Needling of the AV Fistula on the Same Day in Patients on Hemodialysis. N/A
Completed NCT01526798 - Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off Hemodialysis N/A
Completed NCT05285787 - A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD) Phase 2
Completed NCT05769595 - Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012) Phase 1
Completed NCT03119818 - Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy N/A
Completed NCT01228279 - Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis Phase 4
Completed NCT02502903 - Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders Phase 1
Enrolling by invitation NCT06243900 - NIRS for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients
Completed NCT03358030 - A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis Phase 2
Recruiting NCT01415570 - Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease (CKD) N/A
Completed NCT00548249 - Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis Phase 2